相关实验视频
Updated: Jun 8, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
37
关于治疗性结肠炎的黄类药物的研究当前趋势和研究热点:一项文献计量研究
Dingqi Li1, Kaixi Ding1, Wei Jiang1
1College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
概括
本文献分析显示,使用黄类药物治疗性结肠炎 (UC) 的研究趋势越来越强. 关键的研究领域包括肠道菌群,屏障功能和特定的分子通路,葡萄种子化合物显示了最近的重点.
科学领域:
- 药理学和胃肠病学 药理学和胃肠病学
- 图书统计分析 图书统计分析
- 自然产品研究自然产品研究
背景情况:
- 黄类药物对性结肠炎 (UC) 具有显著的治疗潜力.
- 了解UC中黄类药物治疗的作用机制至关重要.
- 图书统计分析为研究趋势和热点提供了洞察力.
研究的目的:
- 对2011年至2022年治疗性结肠炎 (UC) 的黄类药物治疗研究进行文献分析.
- 确定出版趋势,研究热点和该领域的新兴方向.
- 绘制有关黄素和UC的科学成果的地图.
主要方法:
- 在科学网络核心集合上进行的文献搜索.
- 使用的关键词:"黄素"和"性结肠炎" (以及相关术语).
- 使用Bibliometrix,CiteSpace和VOSviewer软件进行的图书识别分析.
主要成果:
- 在2011年至2022年间,发现了181个出版物,年增长率为27.11%.
- 在累计出版物方面,中国领先;金大学是最多产的机构.
- 新兴的研究热点包括肠道菌群,肠道屏障,亡,紧密结节和TLR4/NF-κB通路. 葡萄种类类似物是最近的一个焦点.
结论:
- 本文献计量研究概述了UC黄类药物研究的现状和趋势.
- 它强调了关键的研究领域,并为未来的研究提供了方向.
- 这些发现有助于研究人员识别新兴主题和基于黄胺的UC治疗的最新进展.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Inflammatory Bowel Disease I: Ulcerative Colitis
145
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
145
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
321
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
321
Inflammatory Bowel Disease IV: Pharmacological Management
116
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
116
Chronic Bowel Disorders: Introduction
390
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
390

